KCNA2 Gene Early Infantile Epileptic Encephalopathy Type 32 NGS Genetic DNA Test
Introduction
The KCNA2 Gene Early Infantile Epileptic Encephalopathy Type 32 NGS Genetic DNA Test is an advanced diagnostic tool designed to identify genetic mutations associated with early infantile epileptic encephalopathy (EIEE). This condition is characterized by severe seizures and developmental delays in infants. The test employs Next Generation Sequencing (NGS) technology, allowing for precise detection of genetic anomalies that can lead to these neurological disorders.
What the Test Measures
This genetic test specifically measures alterations in the KCNA2 gene, which plays a critical role in the functioning of potassium channels in the brain. By analyzing the DNA, the test can detect mutations that may be responsible for the onset of early infantile epileptic encephalopathy.
Who Should Consider This Test?
Parents or guardians should consider this test for infants exhibiting symptoms such as:
- Frequent seizures
- Developmental delays
- Unexplained neurological issues
- Family history of epilepsy or neurological disorders
It is particularly recommended for infants who have not responded to standard treatments for seizures.
Benefits of Taking the Test
There are numerous benefits to undergoing the KCNA2 Gene test:
- Early and accurate diagnosis of genetic causes of epilepsy
- Guidance for tailored treatment plans
- Informed family planning decisions based on genetic counseling
- Access to support and resources for managing the condition
Understanding Your Results
Results from the KCNA2 gene test will provide insight into whether a genetic mutation is present. A genetic counselor will help interpret these results and discuss potential implications for the child’s health and future management strategies.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| KCNA2 Gene Early Infantile Epileptic Encephalopathy Type 32 NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Booking the Test
To book the KCNA2 Gene Early Infantile Epileptic Encephalopathy Type 32 NGS Genetic DNA Test, please contact us at +2348077798758 via call or WhatsApp. Our team is ready to assist you with the booking process and any questions you may have.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: A clinical history of the patient is required, along with a genetic counseling session to draw a pedigree chart of family members affected with KCNA2 Gene Early Infantile Epileptic Encephalopathy Type 32.
Consult with a neurologist for further insights and ensure your child receives the best possible care.
